Transcranial magnetic resonance guided focused ultrasound thalamotomy for treatment of medication-refractory essential tremor

Document first published:: 4 November 2020
Page updated:: 5 October 2021
Topic:: Specialised commissioning
Publication type:: Policy or strategy

From 1 April 2021, transcranial magnetic resonance guided focused ultrasound (TcMRgFUS) thalamotomy is recommended to be available as a treatment option through routine commissioning for the treatment of medication refractory essential tremor, in patients that are not eligible for deep brain stimulation, within the criteria set out in this policy.